I will now turn the call over to Ed. Finally, in Q1, we on-boarded new customers in our Medical Distribution division, navigated the seasonality of our patient direct segments and overall met our internal expectations. While Alex will do a deeper dive into our financial performance and expectations for the remainder of 2024, let me review a few of our financial and operational achievements from the first quarter. Turning back to our broader business, we entered the next phase of our operating model realignm ...

Exhibit 99.1 Owens & Minor Reports First Quarter 2024 Financial Results Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined at 2023 Investor Day for Long-Term Growth are Ahead of Plan RICHMOND, VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. Key Highlights: ● Consolidated revenue of $2.6 billion in the first quarter, repre ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 54-1701843 (State or other jurisdiction of (I.R.S ...

Daniel Grosslight - Citi Research Kevin Caliendo - UBS John Stansel - J.P. Morgan Stephanie Davis - Barclays Capital Eric Coldwell - Robert W. Baird Our Patient Direct segment continued to outpace market growth as we leveraged our proven commercial model in one of the fastest growing areas of health care, the home. Before I share my thoughts on 2024 and the future for Owens & Minor, I would like to turn the call over to our Chief Financial Officer, Alex Bruni, to discuss our financial performance and our 20 ...

Fourth Quarter 2023 Supplemental Earnings Slides February 20, 2024 2 Confidential & Proprietary to Owens & Minor, Inc. 1 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ''forward-looking'' statements made pursuant to the Safe Harbor provisions of the Private Se ...

________________________________________________ FORM 10-Q ________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Table of Contents ________________ ...

Okay. And then with Global Products, the minus 14% due to PPE, but you say everything else is strong, I really think we could use some additional help on mix within the segment, i.e., how much is PPE? Where was that, and then how much is the weighting of everything else? If you're down 14% and PPE is only a part of the segment, that means PPE has to be down pretty substantially at this point, which to me is a bit surprising given some of the commentary we're seeing from other distributors and some manufactu ...

Third Quarter 2023 Supplemental Earnings Slides November 3, 2023 2 Confidential & Proprietary to Owens & Minor, Inc. This presentation contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.'s (the "Company") core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________ FORM 10-Q ________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 _____________________ ...

Owens & Minor, Inc. (NYSE:OMI) Q2 2023 Earnings Conference Call August 4, 2023 8:30 AM ET Jackie Marcus - Investor Relations Edward Pesicka - President, Chief Executive Officer Alexander Bruni - Executive Vice President, Chief Financial Officer Kevin Caliendo - UBS Michael Turney - Bank of America Jonathan Yong - Credit Suisse John Stansel - JPMorgan Daniel Grosslight - Citi Eric Coldwell - Baird I would now like to hand the conference over to your first speaker today, Jackie Marcus, Investor Relations. Ple ...